Navigating Regulatory Challenges in Biologics: A Case Study in Overcoming Clinical Holds
In the intricate world of pharmaceuticals and biotechnology, every step of drug development is...
Posts about
Regulatory Submissions (7)
FDA Guidance Series on Patient-Focused Drug Development (PFDD) to Enhance Product Development and Regulatory Decision Making
As the industry continues to adopt a patient-centric approach, the use of real-world data is...
Regulatory Guidance Monthly Review - October 2023
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Executing Patient-Focused Drug Development (PFDD)
Veristat’s Science Advisory Board met on 14 March 2023 to discuss Executing Patient-Focused Drug...
Regulatory Guidance Monthly Review - September 2023
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Unleashing Flexibility in a Rare Disease Gene Therapy Clinical Trial
In the world of biotechnology, where groundbreaking discoveries have the potential to change lives,...
Unlock the Secrets of Effective SD File Preparation for FDA Submissions
In today's world where digital transformation is reshaping industries, even the pharmaceutical...
Regulatory Guidance Monthly Review - August 2023
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Regulatory Guidance Monthly Review - July 2023
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...